Drexel University - Comprehensive, integrated academics enhanced by co-operative education, technology, and research opportunities. | Drexel University
Drexel University
Search events. View events.

All Categories

Click for help in using calendar displays. Print the contents of the current screen.
Display Format: 
Event Details
Notify me if this event changes.Add this event to my personal calendar.
Go Back
Virtual: Psychiatry Grand Rounds
Start Date: 2/9/2022Start Time: 12:00 PM
End Date: 2/9/2022End Time: 1:00 PM

Event Description

Emergency Department-Initiated Buprenorphine for Opioid Use Disorder

Presented By
Gail D'Onofrio, MD, Albert E. Kent Professor of Emergency Medicine and Professor of Epidemiology (Chronic Diseases); Chair, Department of Emergency Medicine, Yale University School of Medicine; Physician‐in Chief of Emergency Services at Yale New Haven Hospital

Learning Objectives

  • Evaluate outcomes for Opioid Use Disorder in patients receiving buprenorphine through the Emergency Department and discuss supporting evidence
  • Identify barriers and solutions to initiating buprenorphine in the Emergency Department
  • Apply harm reduction strategies and components of the buprenorphine integration pathway
  • Discuss innovative solutions for buprenorphine induction in the ED including different formulations of buprenorphine and high dose strategies

Accredidation Statement
Tower Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicans.

Accredidation Statement
Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The course director and members of the planning committee do not have any relevant financial relationships with any commercial interests to disclose regarding today's presentation.

Faculty and all others who have ability to control the content of continuing medical education activities sponsored by Tower Health are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Gail D'Onofrio, MD has no relevant financial relationship﴾s﴿ with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients to disclose. Gail D'Onofrio, MD has indicated the presentation may include discussion of any off‐label uses of a product. Explanation Given: Will be discussing and NIDA grant that has the use of CAM2038 a 7‐day extended release form of buprenorphine. This is under IND. We receive the medication from NIDA and have no contact with the manufacturer

Contact Information:
Name: Grace Dillard
Email: grace.dillard@towerhealth.org
Online Event (Please contact organizer for zoom link)
  • Graduate Students
  • Faculty
  • Staff
  • Medical Residents/Fellows
  • Special Features:
  • Online Access

  • Display Month:

    Advanced Search (New Search)
    Date Range:
    Time Range:

    Special Features: 

    Select item(s) to Search

    Select item(s) to Search
    Select item(s) to Search
    Select item(s) to Search